Pharmacokinetics, safety, and tolerability of phentermine in healthy participants receiving taranabant, a novel cannabinoid-1 receptor (CB1R) inverse agonist.
J Clin Pharmacol
; 49(10): 1228-38, 2009 Oct.
Article
in En
| MEDLINE
| ID: mdl-19783715
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phentermine
/
Pyridines
/
Anti-Obesity Agents
/
Receptor, Cannabinoid, CB1
/
Drug Inverse Agonism
/
Amides
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Clin Pharmacol
Year:
2009
Type:
Article
Affiliation country:
United States